Yuiko Tsukada

Yuiko Tsukada

Auto-generated profile, based on publicly available information

Yuiko Tsukada

Division of Hematology, Department of Medicine, Saiseikai Central Hospital, 1-4-17 Mita, Minato-ku, Tokyo, 108-0073, Japan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2022 in F1000Research
Verified
Journal Article
Open access
PDF file
MHMaki Hirao
Maki Hirao
KYKohei Yamazaki
Kohei Yamazaki
KWKentaro Watanabe
Kentaro Watanabe
KMKiyoshi Mukai
Kiyoshi Mukai
SHShigemichi Hirose
Shigemichi Hirose
YHYutaka Hattori
Yutaka Hattori
Background: The loss of E-cadherin expression and the induction of N-cadherin are known as hallmarks of the epithelial-to-mesenchymal transition, an essential initial step in the process of metastasis in solid tumors. Although several studies have reported expressions of these cadherins in patients with multiple myeloma (MM), their clinical significance is unknown as MM cells are non-epithelial. Methods: In this study, we examined the expression of E- and N-cadherins by immunohistochemistry using bone marrow (BM) biopsy specimens from 31 newly diagnosed MM patients and in subsequent biopsy specimens from six of these. Results: Negative E-cadherin expression on BM myeloma cell membranes was significantly associated with the presence of soft-tissue masses arising from bone lesions and breaking through the cortical bone, referred to as extramedullary disease (EMD). Conclusions: Given the aggressive nature of EMD, our study suggests that screening for E-cadherin using BM immunohistochemistry is one measure that could predict the development of EMD in patients with MM.

28 February 2022 in F1000Research
Verified
Journal Article
Open access
PDF file
MHMaki Hirao
Maki Hirao
KYKohei Yamazaki
Kohei Yamazaki
KWKentaro Watanabe
Kentaro Watanabe
KMKiyoshi Mukai
Kiyoshi Mukai
SHShigemichi Hirose
Shigemichi Hirose
YHYutaka Hattori
Yutaka Hattori
Background: The loss of E-cadherin expression and the induction of N-cadherin are known as hallmarks of the epithelial-to-mesenchymal transition, an essential initial step in the process of metastasis in solid tumors. Although several studies have reported expressions of these cadherins in patients with multiple myeloma (MM), their clinical significance is unknown as MM cells are non-epithelial. Methods: In this study, we examined the expression of E- and N-cadherins by immunohistochemistry using bone marrow (BM) biopsy specimens from 31 newly diagnosed MM patients and in subsequent biopsy specimens from six of these. Results: Negative E-cadherin expression on BM myeloma cell membranes was significantly associated with the presence of soft-tissue masses arising from bone lesions and breaking through the cortical bone, referred to as extramedullary disease (EMD). Conclusions: Given the aggressive nature of EMD, our study suggests that screening for E-cadherin using BM immunohistochemistry is one measure that could predict the development of EMD in patients with MM.

1 January 2022
Verified
Journal Article
Closed access
STSuzuka Tateno
Suzuka Tateno
MHMaki Hirao
Maki Hirao
TKTakahide Kikuchi
Takahide Kikuchi
YTYuiko Tsukada
Yuiko Tsukada
HKHisako Kunieda
Hisako Kunieda
YHYutaka Hattori
Yutaka Hattori